Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Aranzazu Alfranca"'
Autor:
Álvaro Gómez-Morón, Ilya Tsukalov, Camila Scagnetti, Clara Pertusa, Marta Lozano-Prieto, Pedro Martínez-Fleta, Silvia Requena, Pilar Martín, Aranzazu Alfranca, Enrique Martin-Gayo, Noa B Martin-Cofreces
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/83182ebdf4bf4272a6d2e53e7cabd129
Autor:
Álvaro Gómez-Morón, Ilya Tsukalov, Camila Scagnetti, Clara Pertusa, Marta Lozano-Prieto, Pedro Martínez-Fleta, Silvia Requena, Pilar Martín, Aranzazu Alfranca, Enrique Martin-Gayo, Noa B Martin-Cofreces
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionCD8+ cytotoxic T lymphocytes (CTLs) are highly effective in defending against viral infections and tumours. They are activated through the recognition of peptide–MHC-I complex by the T-cell receptor (TCR) and co-stimulation. This cognat
Externí odkaz:
https://doaj.org/article/0ac181f7f4fc4d9c8e1b085025124003
Autor:
Alberto Cecconi, Pablo Martinez-Vives, Alberto Vera, Cristina Lavilla Olleros, Ana Barrios, Eva Fonseca Aizpuru, Pilar Roquero, Susana Hernandez Muñiz, Maria Jose Olivera, Marianela Ciudad, Ruben Pampin Sanchez, Rosa Fernandez-Madera Martínez, Azucena Bautista-Hernández, Elena García Castillo, Gorane Iturricastillo, Elena Ávalos, Diana Prada Cotado, Alvaro Alejandre de Oña, Eduardo Fernandez Carracedo, Ana Marcos-Jimenez, Ancor Sanz-Garcia, Aranzazu Alfranca, Maurizio Cecconi, Hortensia de La Fuente, Maria Angeles Sanz de Benito, Paloma Caballero, Francisco Sanchez-Madrid, Julio Ancochea, Carmen Suarez, Luis Jesus Jimenez-Borreguero, Fernando Alfonso
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Some patients with COVID-19 pneumonia develop an associated cytokine storm syndrome that aggravates the pulmonary disease. These patients may benefit of anti-inflammatory treatment. The role of colchicine in hospitalized patients with COVID-
Externí odkaz:
https://doaj.org/article/f2b88f7320014b5e9fb0dd53ecc74967
Autor:
Miren Uriarte Ecenarro, Daniel Useros, Aranzazu Alfranca, Reyes Tejedor, Isidoro González-Alvaro, Rosario García-Vicuña
Publikováno v:
Diagnostics, Vol 12, Iss 7, p 1773 (2022)
This study aimed to analyze the factors that influence anti-citrullinated protein antibody (ACPA) titers in a seropositive early arthritis (EA) population under non-protocolized treatment with disease-modifying anti-rheumatic drugs (DMARDs). A total
Externí odkaz:
https://doaj.org/article/2e4d4a39d1b84735937434cbca79ce6b
Autor:
Alberto Cecconi, Pablo Martinez-Vives, Alberto Vera, Cristina Lavilla Olleros, Ana Barrios, Eva Fonseca Aizpuru, Pilar Roquero, Susana Hernandez Muñiz, Maria Jose Olivera, Marianela Ciudad, Ruben Pampin Sanchez, Rosa Fernandez-Madera Martínez, Azucena Bautista-Hernández, Elena García Castillo, Gorane Iturricastillo, Elena Ávalos, Diana Prada Cotado, Alvaro Alejandre de Oña, Eduardo Fernandez Carracedo, Ana Marcos-Jimenez, Ancor Sanz-Garcia, Aranzazu Alfranca, Maurizio Cecconi, Hortensia de La Fuente, Maria Angeles Sanz de Benito, Paloma Caballero, Francisco Sanchez-Madrid, Julio Ancochea, Carmen Suarez, Luis Jesus Jimenez-Borreguero, Fernando Alfonso
Publikováno v:
Scientific reports. 12(1)
Artículo escrito por un elevado número de autores, solo se referencian el que aparece en primer lugar, el nombre del grupo de colaboración, si lo hubiere, y los autores pertenecientes a la UAM
Some patients with COVID-19 pneumonia develop an
Some patients with COVID-19 pneumonia develop an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f324aed1776912ef5b6e9fffcaa132d4
https://pubmed.ncbi.nlm.nih.gov/35654818
https://pubmed.ncbi.nlm.nih.gov/35654818
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rosario García-Vicuña, Sebastián C. Rodriguez-García, Francisco Abad-Santos, Azucena Bautista Hernández, Lucio García-Fraile, Ana Barrios Blandino, Angela Gutiérrez Liarte, Tamara Alonso-Pérez, Laura Cardeñoso, Aránzazu Alfranca, Gina Mejía-Abril, Jesús Sanz Sanz, Isidoro González-Alvaro
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundThe use of IL-6 blockers in COVID-19 hospitalized patients has been associated with a reduction in mortality compared to standard care. However, many uncertainties remain pertaining to optimal intervention time, administration schedule, and
Externí odkaz:
https://doaj.org/article/2992076d61d949fdb47177e7a9cfa933